Drugmaker set to profit from unsafe opioid

It's not uncommon for drug companies to try to keep generic versions of their best-selling drugs off the market. But this is a story about a drug company that went to extraordinary lengths to do so, calling into question the safety of a drug it had sold for years. When its plan didn't work, the company made an unusual decision.

Comments

Popular posts from this blog

Canadian transit agency teases amazing new transportation technology: the bus

Amazon’s plans for a New York office are under new scrutiny

Why Twitter should ignore the phony outrage over “shadow banning”